These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 3673721)
41. [Formation of a structural isomer of platelet activating factor during acetylation of 1-alkyl-sn-glycero-3-phosphocholine]. Chupin VV; Ostapenko OV; Klykov VN; Anikin MV; Serebrennikova GA Bioorg Khim; 1993 Nov; 19(11):1111-21. PubMed ID: 8285924 [TBL] [Abstract][Full Text] [Related]
42. [Histamine release from human leukocytes after treatment with 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) and its structural analogs]. Orlov SM; Kulikov VI; Pol'ner AA; Bergel'son LD Biokhimiia; 1985 Apr; 50(4):680-5. PubMed ID: 2408682 [TBL] [Abstract][Full Text] [Related]
43. Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis. Darius H; Lefer DJ; Smith JB; Lefer AM Science; 1986 Apr; 232(4746):58-60. PubMed ID: 3082008 [TBL] [Abstract][Full Text] [Related]
44. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues. Ostermann G; Kertscher HP; Till U Biomed Biochim Acta; 1985; 44(2):K17-23. PubMed ID: 4004829 [TBL] [Abstract][Full Text] [Related]
45. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene. Lefort J; Rotilio D; Vargaftig BB Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375 [TBL] [Abstract][Full Text] [Related]
46. Biosynthesis of paf-acether. Activators of protein kinase C stimulate cultured mast cell acetyltransferase without stimulating paf-acether synthesis. Joly F; Vigrain I; Bossant MJ; Bessou G; Benveniste J; Ninio E Biochem J; 1990 Oct; 271(2):501-7. PubMed ID: 2146953 [TBL] [Abstract][Full Text] [Related]
47. [Interaction of 1-O-alkyl-2-methoxy-sn-glycero-3-phosphocholine and platelet activating factor with blood and tumor cells]. Muzia GI; Orlov SM; Berdyshev EV; Kulikov VI Biokhimiia; 1994 Jul; 59(7):1054-61. PubMed ID: 7948414 [TBL] [Abstract][Full Text] [Related]
48. Synthesis of 1-acyl-2-[3H]acetyl-SN-glycero-3-phosphocholine, a structural analog of platelet activating factor, by vascular endothelial cells. Mueller HW; Nollert MU; Eskin SG Biochem Biophys Res Commun; 1991 May; 176(3):1557-64. PubMed ID: 2039529 [TBL] [Abstract][Full Text] [Related]
49. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor. Breviario F; Bertocchi F; Dejana E; Bussolino F J Immunol; 1988 Nov; 141(10):3391-7. PubMed ID: 3263425 [TBL] [Abstract][Full Text] [Related]
50. Effect of platelet activating factor on the kinetics of LDL oxidation in vitro. Deigner HP; Dresel HA FEBS Lett; 1993 Feb; 317(3):202-6. PubMed ID: 8425606 [TBL] [Abstract][Full Text] [Related]
51. Possible origins of PAF-acether and lyso-PAF-acether in rat lung alveoli secondary to hypoxia. Prévost MC; Cariven C; Chap H Biochim Biophys Acta; 1988 Oct; 962(3):354-61. PubMed ID: 3167085 [TBL] [Abstract][Full Text] [Related]
52. Biosynthesis of paf-acether: VIII: Impairment of paf-acether production in activated macrophages does not depend upon acetyltransferase activity. Roubin R; Dulioust A; Haye-Legrand I; Ninio E; Benveniste J J Immunol; 1986 Mar; 136(5):1796-802. PubMed ID: 3950403 [TBL] [Abstract][Full Text] [Related]
53. Platelet-activating factor (PAF-acether) and microcirculation: effect of Lyso-PAF and PAF-antagonists. Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB Braz J Med Biol Res; 1987; 20(5):595-7. PubMed ID: 3452452 [TBL] [Abstract][Full Text] [Related]
54. Biochemical and pharmacological characterization of human embryo-derived platelet activating factor. Collier M; O'Neill C; Ammit AJ; Saunders DM Hum Reprod; 1988 Nov; 3(8):993-8. PubMed ID: 3204154 [TBL] [Abstract][Full Text] [Related]
55. Production and characterization of specific antibodies against 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a potent hypotensive and platelet-activating ether-linked phospholipid). Nishihira J; Ishibashi T; Imai Y J Biochem; 1984 May; 95(5):1247-51. PubMed ID: 6430883 [TBL] [Abstract][Full Text] [Related]
57. Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin. Morley J; Page CP; Paul W Br J Pharmacol; 1983 Nov; 80(3):503-9. PubMed ID: 6685552 [TBL] [Abstract][Full Text] [Related]
58. Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues. Stimler NP; O'Flaherty JT Am J Pathol; 1983 Oct; 113(1):75-84. PubMed ID: 6624879 [TBL] [Abstract][Full Text] [Related]
59. A PAF-acether antagonist (N 48740 RP/Rhône-Poulenc) and laser-induced thrombi in rat mesenteric vessels. Weichert W; Breddin HK Haemostasis; 1989; 19(4):229-34. PubMed ID: 2807041 [TBL] [Abstract][Full Text] [Related]
60. Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Prescott SM; Zimmerman GA; McIntyre TM Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3534-8. PubMed ID: 6587368 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]